Posted by Dirk Moritz on March 27th, 2019.
Recently, our Rare Diseases Team launched the Blue Matter Breakfast Club. You might ask, “What is the Blue Matter Breakfast Club?” Well, it’s an ongoing series of quarterly two-hour breakfast forums, hosted by our Rare Diseases Team. These forums bring together leaders from companies that develop and commercialize rare disease therapies to discuss critical business issues.
These forums are by invitation, and they offer a private, engaging environment for networking and discussion. To inquire about attending a Breakfast Club event, contact Dirk Moritz, Principal, Rare Diseases at email@example.com.
Breakfast Club Meeting No. 1
We held our first Breakfast Club meeting on 20th March 2019 at Skylounge restaurant in Zug, Switzerland. It was a great success! The meeting opened with an initial address by Dr. Flemming Ornskov, MD, former CEO of Shire Pharmaceuticals. Following Dr. Ornskov’s address, the broader group engaged in an interactive roundtable discussion.
Several key themes were raised and explored during this session. We have attached a summary of that discussion in outline format:
We hope this summary is helpful to all interested readers. To learn more about Blue Matter’s work in rare diseases, please click here.